Pharmacological characterization of the seven human NOX isoforms and their inhibitors

[1]  W. Nauseef,et al.  Isolation of Human Neutrophils from Venous Blood. , 2019, Methods in molecular biology.

[2]  Xuan Wang,et al.  The novel NADPH oxidase 4 selective inhibitor GLX7013114 counteracts human islet cell death in vitro , 2018, PloS one.

[3]  Y. Berdichevsky,et al.  Binding of p67phox to Nox2 is stabilized by disulfide bonds between cysteines in the 369Cys‐Gly‐Cys371 triad in Nox2 and in p67phox , 2018, Journal of leukocyte biology.

[4]  R. Grimley,et al.  Mechanistic enzymology in drug discovery: a fresh perspective , 2017, Nature Reviews Drug Discovery.

[5]  S. Meuth,et al.  NOX4-dependent neuronal autotoxicity and BBB breakdown explain the superior sensitivity of the brain to ischemic damage , 2017, Proceedings of the National Academy of Sciences.

[6]  E. Lobarinas,et al.  Safety and efficacy of ebselen for the prevention of noise-induced hearing loss: a randomised, double-blind, placebo-controlled, phase 2 trial , 2017, The Lancet.

[7]  S. Carnésecchi,et al.  Therapeutic potential of NADPH oxidase 1/4 inhibitors , 2017, British journal of pharmacology.

[8]  A. Shah,et al.  Decoding NADPH oxidase 4 expression in human tumors , 2017, Redox biology.

[9]  Haiching Ma,et al.  Developing selective histone deacetylases (HDACs) inhibitors through ebselen and analogs , 2017, Drug design, development and therapy.

[10]  Edward Ryder,et al.  Genome-wide in vivo screen identifies novel host regulators of metastatic colonization , 2017, Nature.

[11]  S. Taddei,et al.  Impact of apocynin on vascular disease in hypertension. , 2016, Vascular pharmacology.

[12]  A. Goldfine,et al.  Ebselen does not improve oxidative stress and vascular function in patients with diabetes: a randomized, crossover trial. , 2016, American journal of physiology. Heart and circulatory physiology.

[13]  A. Aguzzi,et al.  Evaluation of NADPH oxidases as drug targets in a mouse model of familial amyotrophic lateral sclerosis. , 2016, Free radical biology & medicine.

[14]  H. Schmidt,et al.  NOX4-derived reactive oxygen species limit fibrosis and inhibit proliferation of vascular smooth muscle cells in diabetic atherosclerosis. , 2016, Free radical biology & medicine.

[15]  P. Tsvetkov,et al.  Oxidation of Са2+-Binding Domain of NADPH Oxidase 5 (NOX5): Toward Understanding the Mechanism of Inactivation of NOX5 by ROS , 2016, PloS one.

[16]  D. Laskin,et al.  Selective Targeting of Heme Protein in Cytochrome P450 and Nitric Oxide Synthase by Diphenyleneiodonium. , 2016, Toxicological sciences : an official journal of the Society of Toxicology.

[17]  Sun Choi,et al.  A novel pyrazole derivative protects from ovariectomy-induced osteoporosis through the inhibition of NADPH oxidase , 2016, Scientific Reports.

[18]  K. Krause,et al.  A subset of N-substituted phenothiazines inhibits NADPH oxidases. , 2015, Free radical biology & medicine.

[19]  C. Davies,et al.  Discovery of GSK2795039, a Novel Small Molecule NADPH Oxidase 2 Inhibitor. , 2015, Antioxidants & redox signaling.

[20]  H. Schmidt,et al.  Evolution of NADPH Oxidase Inhibitors: Selectivity and Mechanisms for Target Engagement. , 2015, Antioxidants & redox signaling.

[21]  D. Faigel,et al.  Ebselen inhibits QSOX1 enzymatic activity and suppresses invasion of pancreatic and renal cancer cell lines , 2015, Oncotarget.

[22]  R. Bhatta,et al.  Pharmacokinetic, bioavailability, metabolism and plasma protein binding evaluation of NADPH-oxidase inhibitor apocynin using LC-MS/MS. , 2015, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[23]  Decheng Bai,et al.  A coumarin-based two-photon probe for hydrogen peroxide. , 2015, Biosensors & bioelectronics.

[24]  N. Saito,et al.  The Extracellular A-loop of Dual Oxidases Affects the Specificity of Reactive Oxygen Species Release* , 2015, The Journal of Biological Chemistry.

[25]  L. Scapozza,et al.  Diapocynin, a Dimer of the NADPH Oxidase Inhibitor Apocynin, Reduces ROS Production and Prevents Force Loss in Eccentrically Contracting Dystrophic Muscle , 2014, PloS one.

[26]  J. Lambeth,et al.  Nox4: A Hydrogen Peroxide-Generating Oxygen Sensor , 2014, Biochemistry.

[27]  J. Lambeth,et al.  High-throughput Assays for Superoxide and Hydrogen Peroxide , 2014, The Journal of Biological Chemistry.

[28]  H. Sumimoto,et al.  N-Linked glycosylation of the superoxide-producing NADPH oxidase Nox1. , 2014, Biochemical and biophysical research communications.

[29]  R. Payne,et al.  Assessment of Myeloperoxidase Activity by the Conversion of Hydroethidine to 2-Chloroethidium* , 2014, The Journal of Biological Chemistry.

[30]  J. Lambeth,et al.  On the use of L-012, a luminol-based chemiluminescent probe, for detecting superoxide and identifying inhibitors of NADPH oxidase: a reevaluation. , 2013, Free radical biology & medicine.

[31]  Han Liu,et al.  Characterization of NADPH oxidase 5 expression in human tumors and tumor cell lines with a novel mouse monoclonal antibody. , 2013, Free radical biology & medicine.

[32]  A. Shah,et al.  A 28-kDa Splice Variant of NADPH Oxidase-4 Is Nuclear-Localized and Involved in Redox Signaling in Vascular Cells , 2013, Arteriosclerosis, thrombosis, and vascular biology.

[33]  P. Ortiz de Montellano,et al.  Conserved Cysteine Residues Provide a Protein-Protein Interaction Surface in Dual Oxidase (DUOX) Proteins* , 2013, The Journal of Biological Chemistry.

[34]  Z. Ao,et al.  NADPH oxidase-dependent and -independent mechanisms of reported inhibitors of reactive oxygen generation , 2013, Journal of enzyme inhibition and medicinal chemistry.

[35]  J. Joseph,et al.  Anti-inflammatory and neuroprotective effects of an orally active apocynin derivative in pre-clinical models of Parkinson’s disease , 2012, Journal of Neuroinflammation.

[36]  J. Snyder,et al.  Ebselen and congeners inhibit NADPH oxidase 2-dependent superoxide generation by interrupting the binding of regulatory subunits. , 2012, Chemistry & biology.

[37]  J. Stamler,et al.  Off-target thiol alkylation by the NADPH oxidase inhibitor 3-benzyl-7-(2-benzoxazolyl)thio-1,2,3-triazolo[4,5-d]pyrimidine (VAS2870). , 2012, Free radical biology & medicine.

[38]  M. Sokolowska,et al.  Apocynin reduces reactive oxygen species concentrations in exhaled breath condensate in asthmatics , 2012, Experimental lung research.

[39]  K. Krause,et al.  NADPH oxidase (NOX) isoforms are inhibited by celastrol with a dual mode of action , 2011, British journal of pharmacology.

[40]  E. Rajnavölgyi,et al.  Molecular and Functional Characterization of Hv1 Proton Channel in Human Granulocytes , 2010, PloS one.

[41]  Sophie Houngninou-Molango,et al.  First in class, potent, and orally bioavailable NADPH oxidase isoform 4 (Nox4) inhibitors for the treatment of idiopathic pulmonary fibrosis. , 2010, Journal of medicinal chemistry.

[42]  K. Krause,et al.  Small-molecule NOX inhibitors: ROS-generating NADPH oxidases as therapeutic targets. , 2009, Antioxidants & redox signaling.

[43]  B. Torbett,et al.  Heterodimerization controls localization of Duox-DuoxA NADPH oxidases in airway cells , 2009, Journal of Cell Science.

[44]  S. Belinsky,et al.  Silencing of DUOX NADPH oxidases by promoter hypermethylation in lung cancer. , 2008, Cancer research.

[45]  K. Krause,et al.  NOX5 is expressed at the plasma membrane and generates superoxide in response to protein kinase C activation. , 2007, Biochimie.

[46]  M. S. Galhiane,et al.  The oxidation of apocynin catalyzed by myeloperoxidase: proposal for NADPH oxidase inhibition. , 2007, Archives of biochemistry and biophysics.

[47]  S. Rosenkranz,et al.  Novel Nox inhibitor VAS2870 attenuates PDGF-dependent smooth muscle cell chemotaxis, but not proliferation. , 2006, Cardiovascular research.

[48]  H. Kikuchi,et al.  The NADPH Oxidase Nox3 Constitutively Produces Superoxide in a p22phox-dependent Manner , 2005, Journal of Biological Chemistry.

[49]  Karl-Heinz Krause,et al.  NOX3, a Superoxide-generating NADPH Oxidase of the Inner Ear* , 2004, Journal of Biological Chemistry.

[50]  H. van Dijk,et al.  Effects of methoxylation of apocynin and analogs on the inhibition of reactive oxygen species production by stimulated human neutrophils. , 2001, European journal of pharmacology.

[51]  J. Stolk,et al.  Characteristics of the inhibition of NADPH oxidase activation in neutrophils by apocynin, a methoxy-substituted catechol. , 1994, American journal of respiratory cell and molecular biology.

[52]  Y. Yamamoto,et al.  Action of ebselen as an antioxidant against lipid peroxidation. , 1992, Biochemical pharmacology.

[53]  C. Nathan,et al.  Inhibition of macrophage and endothelial cell nitric oxide synthase by diphenyleneiodonium and its analogs 1 , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[54]  A. Verhoeven,et al.  Characterization of two monoclonal antibodies against cytochrome b558 of human neutrophils. , 1989, Blood.

[55]  A. Cross,et al.  The effect of the inhibitor diphenylene iodonium on the superoxide-generating system of neutrophils. Specific labelling of a component polypeptide of the oxidase. , 1986, The Biochemical journal.

[56]  P. Holland,et al.  Biochemical effects of hypoglycaemic compound diphenyleneiodonium in rat liver mitochondria: inhibition of adenosine triphosphate synthesis. , 1971, Biochemical Journal.

[57]  K. Krause,et al.  The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. , 2007, Physiological reviews.

[58]  W. Nauseef.  Isolation of human neutrophils from venous blood. , 2007, Methods in molecular biology.

[59]  F. D. Moore.  First class. , 1980, The New England journal of medicine.

[60]  S. Gatley,et al.  Some aspects of the pharmacology of diphenyleneiodonium, a bivalent iodine compound. , 1979, Xenobiotica; the fate of foreign compounds in biological systems.